| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | ₹1.3 23.8% | 18,60041.17% |
| 00% | ₹126.7 0% | 820 | ₹2.3 4.54% | 76,7255.31% |
| - | - | 840 | ₹3.25 8.33% | 24,8000% |
| 00% | ₹124 0% | 850 | ₹5.1 34.21% | 27,1250% |
| - | - | 860 | ₹4.4 0% | 32,5500% |
| - | - | 870 | ₹7.95 80.68% | 10,07544.44% |
| 7750% | ₹76.15 0% | 880 | ₹10.1 34.66% | 4,61,9001.70% |
| 6,2000% | ₹68.3 0% | 890 | ₹12.6 34.75% | 25,57526.92% |
| 30,225-7.14% | ₹48.6 -13.44% | 900 | ₹15 31% | 2,74,350-12.15% |
| - | - | 910 | - | - |
| 26,3503.03% | ₹35.3 -14.93% | 920 | ₹22.65 32.06% | 4,06,1001.35% |
| 86,02552.05% | ₹29.6 -18.45% | 930 | ₹27.6 32.05% | 1,41,050142.66% |
| 88,350178.04% | ₹24.85 -18.92% | 940 | ₹32.9 29.01% | 1,44,1505.08% |
| 2,81,3255.83% | ₹20.5 -21.15% | 950 | ₹38.8 28.9% | 2,13,125-5.49% |
| 2,17,00014.75% | ₹17 -21.11% | 960 | ₹46.3 30.05% | 1,49,5754.32% |
| 1,06,950-2.12% | ₹14 -20.45% | 970 | ₹53.7 30.97% | 98,425-0.78% |
| 1,30,9756.96% | ₹11.6 -18.59% | 980 | ₹56.95 20.27% | 23,25011.11% |
| 68,2007.31% | ₹9.55 -17.67% | 990 | ₹49.85 0% | 7750% |
| 5,11,50013.98% | ₹8.05 -14.36% | 1,000 | ₹75.95 22.1% | 33,325-10.41% |
| 34,10041.93% | ₹6.85 -10.45% | 1,010 | ₹64.45 0% | 1,5500% |
| 1,04,6257.14% | ₹5.75 -5.73% | 1,020 | - | - |
| 27,900350% | ₹5 2.04% | 1,030 | - | - |
| 9,54,800377.51% | ₹4.25 6.25% | 1,040 | - | - |
| 71,30010.84% | ₹3.45 9.52% | 1,050 | - | - |
| 31,000-6.97% | ₹2.8 9.8% | 1,060 | - | - |
| 22,475-39.58% | ₹2.5 38.88% | 1,080 | - | - |
| 37,20060% | ₹1.7 54.54% | 1,100 | - | - |
| 12,40014.28% | ₹1.25 25% | 1,120 | ₹182.6 13.62% | 8,5250% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
